SecBot SecBot

QSI

Quantum-Si Inc
Nasdaq· Measuring & Controlling Devices, NEC· Inc. DE· CIK 0001816431 Industrials & Manufacturing
$1.46 +0.06 (+4.29%)
Oct 26 4:00 PM ET · prev $1.40
Market cap
$251.7M
Micro cap
Consensus
Buy
71% Buy or better · 7 analysts
Median target
$1.90
+30% · range $1.00–3.95
Next earnings
Nov 5
in 9 days · EPS est. −$0.12
1 year
−37.6%
from $2.34 · Oct 27
30 days
+83.6%
from $0.7950
52-week range
$0.7020–2.34
−38% from high · low Jul 29
Avg volume 20D
12.70M
Oct 9 spike 40.90M
Short interest
🔒 Subscribers only
Insider net
+$155.7K
2 buyers · 4 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Reddit crowd
61°
Warm · 5 mentions this week
SecBot read BULLISH 6 reports · 90 days
Balance 0 bearish · 1 bullish · 5 neutral oldest → newest, height = score
Avg score ·High conf. 6/6 ·Next Earnings date, Nov 5, 2026
Strongest BULLISH Quantum-Si presented interim development data for its next-generation Proteus platform at World HUPO 2026…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersMIXED

    2 insiders bought $564.3K at an average $0.9252. 4 insiders sold $408.5K. Price is 58% above their cost.

  • InstitutionsBEARISH

    Q2 2026: 12 added (0 new), 21 trimmed or exited.

  • AnalystsBULLISH

    5 of 7 rate it Buy or better. Median target $1.90 (+30%).

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.110 → −$0.120 over 90 days. 0 up, 1 down in 30 days.

  • TrendUPTREND

    50% above its 50-day average.

  • SocialQUIET

    Crowd 61° (warm) this week from 5 mentions: 2 bullish, 0 bearish. No setup call. Excludes 1 subscriber-only day.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
BlackRock, Inc.TRIM5,225,352$4.6M
UBS Group AGADD2,561,897$2.3M
GEODE CAPITAL MANAGEMENT, LLCTRIM2,236,526$2.0M
STATE STREET CORPNEAR_EXIT890,741$788.3K
RENAISSANCE TECHNOLOGIES LLCDOUBLED553,871$490.2K
VANGUARD PORTFOLIO MANAGEMENT LLCTRIM497,098$439.9K
NORTHERN TRUST CORPTRIM450,531$398.7K
BNP PARIBAS FINANCIAL MARKETSDOUBLED398,598$352.8K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

7 analysts
Buy 71% rate it Buy or better
Strong Buy1Buy4Hold2Sell0Strong Sell0
12-month targets · 3 analysts

Price is inside the target range. Median implies +30%.Targets as of Oct 27, 2026.

Recent actions
DateFirmActionRating
Sep 29, 2026HC Wainwright & Co.
REITERATE
REITERATEBuy
Reddit mentions per day, 14 days
Crowd this week 61° Warm 2 bullish · 0 bearish
Mentions, 7 days 5 1 in posts · 4 in comments
Recent posts
r/pennystocks Bullish 2d ago
Three proteomics biotech penny stocks: NAUT, QSI and PACB
1 upvotes · 0 comments
r/pennystocks Neutral 26d ago
01 OCT 2026 , WHAT ARE THE BIGGEST WINNERS AND WHY ?
1 upvotes · 1 comments
r/pennystocks Neutral 26d ago
02 OCTOBER 2026 , WHAT ARE THE BIGGEST WINNERS AND WHY ?
1 upvotes · 1 comments
r/pennystocks Bullish 26d ago
QSI is under accumulation
1 upvotes · 2 comments
Recent comments
r/pennystocks1d ago
Fresh comment, for subscribers
r/pennystocks Bullish 2d ago
I was watching QSI without really "getting it." All of the sudden they announced that they had 18 (of 20) proteins mapped. I got excited and then two days later they announced 19. I'm thinking, "What am I watching?" The guy that runs QSI is a serial biotech guru and he's done some amazing stuff. ALL of these would be in a much, much better position if money were a lot cheaper like it was six months ago.
r/pennystocks Neutral 2d ago
That PACB line barely twitching upward while NAUT ran 200%+ says a lot about where the speculative money is flowing. The Voyager platform doesn't even have a commercial product yet and traders are piling in like it's already printing cash. QSI catching a 78% bump while still sorting out launch delays is something. The ag and gene therapy pivot is smart but they need to actually ship before the runway gets too short.
r/wallstreetbets Neutral 4d ago
QSI
All social signals and their track records

Insider ledger

Form 4
$564.3K
bought · 2 insiders
$408.5K
sold · 4 insiders
+57.8%
vs their $0.9252 cost
DateInsiderTypeValue
Sep 22, 2026
LaPointe Christian
GC & Corp. Secretary
SELL$3.6K
Sep 22, 2026
Keyes Jeffry R.
Chief Financial Officer
SELL$1.9K
Sep 22, 2026
Hawkins Jeffrey Alan
President & CEO
SELL$7.4K
Sep 21, 2026
LaPointe Christian
GC & Corp. Secretary
SELL$7.4K
Sep 21, 2026
Keyes Jeffry R.
Chief Financial Officer
SELL$3.9K
Sep 21, 2026
Hawkins Jeffrey Alan
President & CEO
SELL$15.2K
Jun 23, 2026
Hawkins Jeffrey Alan
President & CEO
SELL$10.2K
Jun 23, 2026
Vieceli John S.
Chief Product Officer
SELL$13.6K

Earnings setup

Estimates
Nov 5
reports in 9 days
−$0.12
EPS estimate, this quarter
−9%
estimate change, 90 days
0↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.12-$0.12–-$0.12-9.1%$268.3K
Next Q-$0.10-$0.10–-$0.10+9.1%$242.3K
Current FY-$0.40-$0.40–-$0.40+0.0%$1.1M
Next FY-$0.35-$0.35–-$0.35+2.8%$5.8M

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 15, 2026 SEC
Quantum-Si Inc. (QSI) received formal notice from Nasdaq on October 14, 2026, that it has regained compliance with the…
8-K — Impact 3/10
Oct 15, 2026 Press
Quantum-Si Incorporated announced it has regained compliance with Nasdaq's minimum bid price requirement, resolving a…
Impact 3/10
Oct 15, 2026 Regulatory
Quantum-Si Regains Compliance with Nasdaq Minimum Bid Price Requirement
Quantum-Si Regains Compliance with Nasdaq Minimum Bid Price Requirement...
Oct 8, 2026 SEC
Quantum-Si announced it has demonstrated detection of 19 amino acids in its Proteus development program, an…
8-K — Impact 4/10
Sep 28, 2026 SEC
Quantum-Si presented interim development data for its next-generation Proteus platform at World HUPO 2026, showing…
8-K — Impact 6/10
Sep 22, 2026 Insider
LaPointe Christian sold 4,721 shares
GC & Corp. Secretary @ $0.7608 ($3.6K)
Sep 22, 2026 Insider
Keyes Jeffry R. sold 2,493 shares
Chief Financial Officer @ $0.7608 ($1.9K)
Sep 22, 2026 Insider
Hawkins Jeffrey Alan sold 9,709 shares
President & CEO @ $0.7608 ($7.4K)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 5, 2026
Earnings date
QSI Q3 2026 Earnings Scheduled — 2026-11-05
Recent
Oct 15, 2026
Regulatory
Quantum-Si Regains Compliance with Nasdaq Minimum Bid Price Requirement
Quantum-Si Regains Compliance with Nasdaq Minimum Bid Price Requirement...
Oct 14, 2026
Listing
Listing Status: QSI — Normal (was Deficient)
Quantum-Si Incorporated - Class A Common Stock | Nasdaq Financial Status Indicator D → N
Sep 28, 2026
Press release
Quantum-Si Presents Interim Proteus™ Data at World HUPO 2026 Demonstrating a Significant Step Change in Performance Compared to Platinum® Pro
Quantum-Si Presents Interim Proteus™ Data at World HUPO 2026 Demonstrating a Significant Step Change in Performance Compared to Platinum ® Pro
Aug 13, 2026
Earnings date
QSI Q2 2026 Earnings Scheduled — 2026-08-13
Aug 3, 2026
Earnings date
QSI Q2 2026 Earnings Scheduled — 2026-08-03

SecBot reports

11 filings · 1 press release · 2 bullish · 0 bearish · 9 neutral
All QSI filing & press-release reports (12)